Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With131I-Metaiodobenzylguanidine (MIBG)-Reference-Cited by-同舟云学术

Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With131I-Metaiodobenzylguanidine (MIBG)

Published:2015-10-27 Issue:3 Volume:63 Page:436-442
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Trieu Megan¹,DuBois Steven G.¹,Pon Elizabeth¹,Nardo Lorenzo²,Hawkins Randall A.²,Marachelian Araz³,Twist Clare J.⁴,Park Julie R.⁵,Matthay Katherine K.¹

Affiliation:

1. Department of Pediatrics; UCSF School of Medicine and UCSF Benioff Children's Hospital; University of California San Francisco; San Francisco California

2. Department of Radiology; UCSF School of Medicine and UCSF Benioff Children's Hospital; University of California San Francisco; San Francisco California

3. Department of Pediatrics; Keck School of Medicine; University of Southern California and Children's Hospital Los Angeles; Los Angeles California

4. Department of Pediatrics; Lucile Packard Children's Hospital; Palo Alto California

5. Department of Pediatrics; University of Washington School of Medicine; Seattle Washington

Funder

Alex's Lemonade Stand Foundation POST Award

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference38 articles.

1. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children's oncology group study;Matthay;J Clin Oncol,2009

2. Neuroblastoma and other neuroendocrine tumors;Howman-Giles;Semin Nucl Med,2007

3. Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma;Taggart;Q J Nucl Med Mol Imaging,2008

4. A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma;Wilson;Eur J Cancer,2014

5. Optimization of molecular radiotherapy with [131I]-meta iodobenzylguanidine for high-risk neuroblastoma;Gaze;Q J Nucl Med Mol Imaging,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of subclinical and overt hypothyroidism in children treated with [131I]mIBG: a systematic review and meta-analysis;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2024-04

2. Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma;Seminars in Nuclear Medicine;2023-07

3. Modulation of Radiation Biomarkers in a Randomized Phase II Study of 131I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma;International Journal of Radiation Oncology*Biology*Physics;2023-04

4. Radiobiology and Radiation Dosimetry in Nuclear Medicine;Nuclear Oncology;2022

5. Radiobiology and Radiation Dosimetry in Nuclear Medicine;Nuclear Oncology;2022